PEGylation enables subcutaneously administered nanoparticles to induce antigen-specific immune tolerance
- 12 January 2021
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 331, 164-175
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Drexel University
- National Institute of Allergy and Infectious Diseases (R21AI133372)
- Juvenile Diabetes Research Foundation United States of America (1-PNF-2018-658-A-N)
- Directorate for Engineering (1839505)
- CURE Childhood Cancer
- Pennsylvania Department of Health
- National Science Foundation
- Oregon Clinical and Translational Research Institute
This publication has 59 references indexed in Scilit:
- Engineering antigens for in situ erythrocyte binding induces T-cell deletionProceedings of the National Academy of Sciences, 2012
- Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitisNature Biotechnology, 2012
- Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitisProceedings of the National Academy of Sciences, 2012
- Treating Human Autoimmunity: Current Practice and Future ProspectsScience Translational Medicine, 2012
- The role of CD40 and CD154/CD40L in dendritic cellsSeminars in Immunology, 2009
- TLR3-Stimulated Dendritic Cells Up-regulate B7-H1 Expression and Influence the Magnitude of CD8 T Cell Responses to Tumor VaccinationThe Journal of Immunology, 2009
- Complement regulators and inhibitory proteinsNature Reviews Immunology, 2009
- Antigen-Specific Suppression of Inflammatory Arthritis Using LiposomesThe Journal of Immunology, 2009
- Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitisProceedings of the National Academy of Sciences, 2008
- Antigen kinetics determines immune reactivityProceedings of the National Academy of Sciences, 2008